Increasing inequality across Europe is a huge challenge to policy-makers in all areas, not least health policy. Income inequality in OECD countries is higher today than at any time in the last fifty years, which has profound impacts on the health and wellbeing of the...
EPHA calls on the Commission to present evidence that TTIP will actually lead to lower prices for medicines in Europe, rather than a convergence with the even higher prices that are today’s reality in the USA. Affordability of medicines should be included as a key...
Affordability of medicines The European Commission maintains that closer cooperation on trade in medicines in TTIP will lead to cost savings for pharmaceutical companies. However, it is not clear that any cost savings will translate to lower prices of medicines for...
The European Public Health Alliance (EPHA) welcomes the ECJ judgement and calls for all EU and national institutions to respect the global Framework Convention on Tobacco Control to reduce the damage done by tobacco products worldwide, including 700,000 premature...
EPHA believes that greater transparency is vital to ensure proper democratic and public debate about the impact of trade policy on population health, following Greenpeace Netherlands’ release of classified TTIP negotiating documents. Brussels, 2nd May 2016. EPHA...
PRESS RELEASE | European Parliament’s vote turns health into a trade secret opening the way for shady TTIP negotiations European Parliament’s vote turns health into a trade secret Trade Secrets Directive opens the way for shady TTIP negotiations Brussels, 14 April...